Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1 1

Status

Completed 17Active not recruiting 5Terminated 4Recruiting 3Unknown 1Available 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4Gastrointestinal 4

Conditions

Carcinoma, Renal Cell 27Neoplasms 9Neoplasm Metastasis 9Breast Neoplasms 9Kidney Neoplasms 6Prostatic Neoplasms 4Gastrointestinal Stromal Tumors 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplasms by Histologic Type 3Melanoma 3Liver Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Acute 3Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Primary Myelofibrosis 2Neuroendocrine Tumors 2Neoplasms, Glandular and Epithelial 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Site 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Digestive System Neoplasms 2Clear-cell metastatic renal cell carcinoma 2

Interventions

Imatinib Mesylate 10Sunitinib 4spartalizumab 2pembrolizumab 2nilotinib 2Surveys and Questionnaires 2tanespimycin 1ribociclib 1pexidartinib 1pazopanib 1olaratumab 1oblimersen 1motexafin lutetium 1masitinib 1guadecitabine 1ferric carboxymaltose 1famitinib 1epacadostat 1Surgical Procedures, Operative 1Quality of Life 1Observation 1Iron-Dextran Complex 1Indocyanine Green 1Immunoglobulin G 1Fluorescein 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Gastrointestinal Stromal Tumors × Sunitinib × Clear all
NCT04409223 2024-02-09

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Terminated
185 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01054911 2016-09-22

Evaluation of Patients With Bulky GIST Using Sunitinib

University of Alabama at Birmingham

Phase NA Terminated
5 enrolled 4 charts
GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT00573404 2011-11-16

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Vanderbilt-Ingram Cancer Center

Phase 1 Terminated
6 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00372567 2011-03-17

Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors

Pfizer

Phase 3 Terminated
69 enrolled 22 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡